Biomerica appoints Eric Chin to board; Cathy Coste resigns effective June 4

BIOMERICA INC

Cathy Coste resigned as director effective June 4, 2025; no disagreement with the company.
Eric Chin appointed as independent director and Audit Committee Chair, effective same date.
Chin is CFO of Akido Labs, helped raise $60M; will receive $41K annual cash and 10,000 restricted shares.
Chin also joins Nominating/Governance and Compensation Committees.
No family relationships or transactions requiring disclosure; board determined independent per Nasdaq rules.

item 5.02item 7.01item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Eric Chin

Director and Audit Committee Chair

BMRA · BIOMERICA INC

Effective: 2025-06-04
Filed: Jun 06, 2025 23:59 UTC

On the same date, the Board appointed Mr. Eric Chin to serve as an independent member of the Board, effective immediately

Departed

Cathy Coste

Director

BMRA · BIOMERICA INC

Effective: 2025-06-04
Successor: Eric Chin
Filed: Jun 06, 2025 23:59 UTC

Effective June 4, 2025, Ms. Cathy Coste stepped down as a member of the Board of Directors

Source: SEC EDGAR

accession 0001641172-25-013942

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.